Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sp-3164 save search
Salarius Pharmaceuticals Receives FDA Clearance of SP-3164 Investigational New Drug Application to Begin a Phase 1 Clinical Trial in Relapsed/Refractory Non-Hodgkin Lymphoma Patients
Published: 2023-07-11 (Crawled : 12:20) - globenewswire.com
SLRX | $0.4848 -2.88% 6.2K
|
Commercial Services
|
| O: 3.45%
H: 0.01%
C: -15.33%
sp-3164 fda drug clearance pharmaceuticals application trial
Salarius Pharmaceuticals Presents SP-3164 Targeted Protein Degrader Preclinical Data at the European Hematology Association 2023 Hybrid Congress
Published: 2023-06-12 (Crawled : 12:00) - globenewswire.com
SLRX | $0.4848 -2.88% 6.2K
|
Commercial Services
|
| O: 6.06%
H: 0.0%
C: -5.71%
sp-3164 association pharmaceuticals preclinical protein
Salarius Pharmaceuticals Reports No Adverse Safety Signals from Two Good Laboratory Practice Toxicology Studies with its Targeted Protein Degrader SP-3164
Published: 2023-05-01 (Crawled : 14:20) - globenewswire.com
SLRX | $0.4848 -2.88% 6.2K
|
Commercial Services
|
| O: 2.25%
H: 0.55%
C: -1.65%
sp-3164 pharmaceuticals protein
Salarius Pharmaceuticals Presents Compelling Data in Two SP-3164 Targeted Protein Degrader Posters at the American Association for Cancer Research Annual Meeting
Published: 2023-04-20 (Crawled : 14:20) - biospace.com/
SLRX | $0.4848 -2.88% 6.2K
|
Commercial Services
|
| O: -8.6%
H: 1.76%
C: -2.35%
sp-3164 association cancer pharmaceuticals research protein meeting
Salarius Pharmaceuticals Presents SP-3164 Preclinical Data at the Inaugural Molecular Glue Drug Development Summit
Published: 2023-01-27 (Crawled : 20:00) - biospace.com/
SLRX | $0.4848 -2.88% 6.2K
|
Commercial Services
|
| O: 1.95%
H: 5.75%
C: -7.28%
sp-3164 pharmaceuticals drug preclinical molecular
Salarius Pharmaceuticals to Present SP-3164 Targeted Protein Degrader Preclinical Data at the Inaugural Molecular Glue Drug Development Summit
Published: 2023-01-19 (Crawled : 14:00) - globenewswire.com
SLRX | $0.4848 -2.88% 6.2K
|
Commercial Services
|
| O: 0.0%
H: 75.21%
C: 52.99%
sp-3164 pharmaceuticals drug preclinical molecular
Salarius Pharmaceuticals Presents SP-3164 Data Demonstrating Activity in Preclinical Lymphoma Models at the American Society of Hematology Annual Meeting
Published: 2022-12-13 (Crawled : 14:20) - biospace.com/
SLRX | $0.4848 -2.88% 6.2K
|
Commercial Services
|
| O: 7.45%
H: 4.95%
C: -11.88%
sp-3164 pharmaceuticals preclinical meeting
Salarius Pharmaceuticals Presents Favorable Preclinical Data on SP-3164 at the 5th Annual Targeted Protein Degradation Conference
Published: 2022-10-27 (Crawled : 14:00) - biospace.com/
SLRX | $0.4848 -2.88% 6.2K
|
Commercial Services
|
| O: -1.23%
H: 0.93%
C: -13.33%
sp-3164 pharmaceuticals conference preclinical
Salarius Pharmaceuticals to Present SP-3164 at the 5th Annual Targeted Protein Degradation Conference
Published: 2022-10-19 (Crawled : 13:00) - globenewswire.com
SLRX | $0.4848 -2.88% 6.2K
|
Commercial Services
|
| O: -1.5%
H: 0.37%
C: -14.44%
sp-3164 pharmaceuticals conference
Salarius Pharmaceuticals Completes SP-3164 Pre-Investigational New Drug Meeting Process with the U.S. Food and Drug Administration
Published: 2022-05-11 (Crawled : 21:00) - biospace.com/
SLRX | $0.4848 -2.88% 6.2K
|
Commercial Services
|
| O: 3.84%
H: 6.25%
C: -20.0%
sp-3164 drug food
PAVmed Subsidiary Lucid Diagnostics Receives CE Mark Certification for its EsoCheck® Esophageal Cell Collection Device
Published: 2021-05-26 (Crawled : 14:00) - globenewswire.com
PAVM | $1.95 -1.03% 20K
|
Health Technology
|
| O: 0.63%
H: 7.95%
C: 7.11%
ce mark device diagnostics diagnostic lucid-ms
SFL – Successful placement of 5-year inaugural sustainability-linked bonds
Published: 2021-04-29 (Crawled : 16:00) - shipfinance.bm
SFL | News | $12.71 2.01% 0.0% 540K
|
Transportation
|
| O: 0.9%
H: 1.08%
C: 0.64%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.